Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Ephyra New

Ephyra appoints Chair - Peter Simpson

Portfolio company, Ephyra, recently announced the appointment of their new Chair.

We are pleased to share the latest news from portfolio company Ephyra. The team has appointed Dr. Peter Simpson as Chair of its Board of Directors.

Peter has a strong leadership background in life sciences and experience advising other SMEs, including helping raise early-stage funding.

His guidance will help the company form and develop strategic partnerships, and drive the development of their designer sponge RNAs, that can target disease-causing molecules to restore a healthy balance and treat diseases.

To learn more about Ephyra, visit